11/14
11:13 am
clnn
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $86.00 to $83.00. They now have a "buy" rating on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $86.00 to $83.00. They now have a "buy" rating on the stock.
11/14
08:15 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
11/13
10:21 am
clnn
Clene Inc. (CLNN) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
Low
Report
Clene Inc. (CLNN) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
11/13
08:00 am
clnn
Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights
Medium
Report
Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights
10/24
08:08 am
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
10/21
01:38 pm
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences [Yahoo! Finance]
Medium
Report
IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences [Yahoo! Finance]
10/11
03:13 pm
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements [Yahoo! Finance]
Low
Report
IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements [Yahoo! Finance]
10/9
08:00 am
clnn
Clene to Present at Upcoming October Conferences
High
Report
Clene to Present at Upcoming October Conferences
10/5
10:09 am
clnn
Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares [Yahoo! Finance]
Low
Report
Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares [Yahoo! Finance]
10/4
11:36 am
clnn
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $94.00 to $86.00. They now have a "buy" rating on the stock.
Medium
Report
Clene Inc. (NASDAQ: CLNN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $94.00 to $86.00. They now have a "buy" rating on the stock.
10/3
10:58 am
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M [Yahoo! Finance]
Low
Report
IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M [Yahoo! Finance]
10/2
07:37 am
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements [Yahoo! Finance]
Medium
Report
IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements [Yahoo! Finance]
10/1
04:00 pm
clnn
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
Medium
Report
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
9/30
08:58 am
clnn
Clene launches $7.3M registered direct offering [Seeking Alpha]
Medium
Report
Clene launches $7.3M registered direct offering [Seeking Alpha]
9/30
08:30 am
clnn
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
High
Report
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
9/26
12:09 pm
clnn
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership [Yahoo! Finance]
Low
Report
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership [Yahoo! Finance]
9/16
02:04 pm
clnn
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Low
Report
Clene Inc. (NASDAQ: CLNN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
9/16
08:30 am
clnn
Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
High
Report
Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
9/12
07:24 am
clnn
Clene Inc. (NASDAQ: CLNN) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.
Medium
Report
Clene Inc. (NASDAQ: CLNN) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.
9/3
10:59 am
clnn
IBN Coverage: Clene (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases [Yahoo! Finance]
Medium
Report
IBN Coverage: Clene (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases [Yahoo! Finance]
9/3
08:00 am
clnn
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
High
Report
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
8/29
12:35 pm
clnn
IBN Coverage: Clene (NASDAQ: CLNN) CEO Discusses CNM-Au8(R) Trial Results on BioMedWire Podcast [Yahoo! Finance]
Low
Report
IBN Coverage: Clene (NASDAQ: CLNN) CEO Discusses CNM-Au8(R) Trial Results on BioMedWire Podcast [Yahoo! Finance]
8/23
10:42 am
clnn
IBN Coverage: Clene's (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers, Long-term Survival in ALS Trials [Yahoo! Finance]
Low
Report
IBN Coverage: Clene's (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers, Long-term Survival in ALS Trials [Yahoo! Finance]